ArticleTropical medicine and infectious disease2026
Acceptability of Integrated Vector Management of
Article in Tropical medicine and infectious disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
For dengue, there is little evidence regarding community-level acceptance, facilitators and barriers for integrated vector management (IVM). We carried out a survey to measure these aspects in the context of a large cluster-randomized controlled trial of IVM against dengue vectors in urban Malaysia, in which the component control methods were (i) outdoor residual spraying, (ii) autodissemination devices (ADDs) and (iii) community engagement. The survey population comprised (i) members of the Joint Management Body (JMB) of building developments in both arms, and (ii) residents in the intervention arm. Members of both groups were requested to complete a structured questionnaire, through face-to-face interviews. Among JMB responders, 138 were the intervention clusters, and 94 from those receiving routine activities (control arm), and there were 604 responders among residents of intervention clusters. Among the JMB members, safety of the control methods (spraying and ADDs) was among the most important potential facilitators. Among barriers, the ones identified by over one-third of the participants were lack of information about the iDEM IVM methods, lack of communication and of involvement with the iDEM project personnel. Overall, the iDEM IVM methods were seen positively, and investment by the trial in community engagement may have contributed to this.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.